Schedule 13G ownership disclosure

Nexvet Biopharma plc

Security class unavailable · CUSIP: G6503X109

Event date: 2016-06-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
695,700
Percent of class
5.9300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001694164-17-000001
Form type
SC 13G
Filer
AustralianSuper Pty Ltd
CIK
CIK 1694164
Filed
Jan 11, 2017
Reporting period
Jun 22, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub